Data di Pubblicazione:
2019
Abstract:
Mantle cell lymphoma (MCL) is an aggressive lymphoma sub-type with poor prognosis and high 18F-FDG avidity at PET/CT; nowadays, no validated criteria for PET/CT in treatment response evaluation and prediction of outcome are present. The aim of study was to investigate whether the metabolic PET/CT features may predict treatment evaluation and prognosis in MCL.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
18F-FDG PET/CT; MTV; Mantle cell lymphoma; Prognosis; TLG
Elenco autori:
Albano, Domenico; Bosio, Giovanni; Bianchetti, Nicola; Pagani, Chiara; Re, Alessandro; Tucci, Alessandra; Giubbini, Raffaele; Bertagna, Francesco
Link alla scheda completa:
Pubblicato in: